ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,816 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBasel3T Biosciences Europe GmbH
3T Biosciences Europe GmbH Logo
Verified· 2 sources

3T Biosciences Europe GmbH

Summary

About the company

The core activity of 3T Biosciences is the development of immunotherapies, specifically the identification and validation of T-cell receptor targets and specificities for the treatment of cancer and other immune-mediated diseases. The company utilizes its proprietary 3T-TRACE platform technology, which is based on machine learning algorithms and diverse target libraries.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Pharmaceutical Industry
✓ Offered4
Development of TCR therapeutics
Development of next-generation therapies for solid tumours and other immune-mediated diseases, based on T-cell receptors, TCRm and precision immunology approaches.
3T-TRACE platform
Platform for the identification and validation of TCR targets and specificities, with diverse target libraries, machine learning, high-throughput screening and cross-reactivity analysis.
Target discovery and validation
Identification of new shared TCR targets from patient samples, screening of reactive TCRs and validation of specificity as well as off-target cross-reactivities.
Cooperations in biopharma and research
Partnerships with industry and academic institutions to accelerate target discovery and therapeutic development around the 3T-TRACE platform.

Knowledge

No knowledge articles yet

Once 3T Biosciences Europe GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

3T Biosciences Europe GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank 3T Biosciences Europe GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of 3T Biosciences Europe GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grosspeteranlage 29
4052 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-204.667.977
Founded
2022 · 4 years
Last commercial register change
July 4, 2024
Employees
21 to 50

Similar companies

YA
youEngineering AG
Basel
IF
International Foundation for Patient Blood Management (IFPBM)
Basel
LM
Laevoroc Medical AG
Basel
FT
FoRx Therapeutics AG
Basel
EP
Eumedica Pharmaceuticals AG
Basel
BA
BioVersys AG
Basel
ET
Elanco Tiergesundheit AG
Basel
NA
NBE-Therapeutics AG
Basel